Annual Operating Profit:
$54.40M+$209.97M(+134.97%)Summary
- As of today, ESPR annual operating income is $54.40 million, with the most recent change of +$209.97 million (+134.97%) on December 31, 2024.
- During the last 3 years, ESPR annual operating profit has risen by +$281.13 million (+123.99%).
- ESPR annual operating profit is now at all-time high.
Performance
ESPR Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Operating Profit:
-$9.96M-$17.05M(-240.37%)Summary
- As of today, ESPR quarterly operating income is -$9.96 million, with the most recent change of -$17.05 million (-240.37%) on September 30, 2025.
- Over the past year, ESPR quarterly operating profit has increased by +$6.07 million (+37.86%).
- ESPR quarterly operating profit is now -107.71% below its all-time high of $129.17 million, reached on June 30, 2020.
Performance
ESPR Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Operating Profit:
-$29.38M+$6.07M(+17.12%)Summary
- As of today, ESPR TTM operating income is -$29.38 million, with the most recent change of +$6.07 million (+17.12%) on September 30, 2025.
- Over the past year, ESPR TTM operating profit has dropped by -$58.94 million (-199.41%).
- ESPR TTM operating profit is now -154.01% below its all-time high of $54.40 million, reached on December 31, 2024.
Performance
ESPR TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
ESPR Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +135.0% | +37.9% | -199.4% |
| 3Y3 Years | +124.0% | +76.1% | +84.8% |
| 5Y5 Years | +158.4% | +87.6% | +65.3% |
ESPR Operating Profit Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +124.0% | -113.8% | +79.5% | -154.0% | +84.8% |
| 5Y | 5-Year | at high | +124.0% | -113.8% | +89.6% | -154.0% | +89.9% |
| All-Time | All-Time | at high | +124.0% | -107.7% | +89.6% | -154.0% | +89.9% |
ESPR Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$9.96M(-240.4%) | -$29.38M(+17.1%) |
| Jun 2025 | - | $7.09M(+132.1%) | -$35.45M(+11.3%) |
| Mar 2025 | - | -$22.10M(-399.9%) | -$39.96M(-173.5%) |
| Dec 2024 | $54.40M(+135.0%) | -$4.42M(+72.4%) | $54.40M(+84.1%) |
| Sep 2024 | - | -$16.03M(-721.4%) | $29.55M(+63.8%) |
| Jun 2024 | - | $2.58M(-96.4%) | $18.05M(+183.6%) |
| Mar 2024 | - | $72.27M(+346.9%) | -$21.59M(+84.8%) |
| Dec 2023 | -$155.56M(+13.3%) | -$29.27M(-6.3%) | -$142.46M(+8.5%) |
| Sep 2023 | - | -$27.53M(+25.7%) | -$155.71M(+8.3%) |
| Jun 2023 | - | -$37.06M(+23.8%) | -$169.80M(+8.3%) |
| Mar 2023 | - | -$48.60M(-14.3%) | -$185.12M(-3.1%) |
| Dec 2022 | -$179.50M(+20.8%) | -$42.51M(-2.1%) | -$179.50M(+6.8%) |
| Sep 2022 | - | -$41.62M(+20.5%) | -$192.62M(+6.8%) |
| Jun 2022 | - | -$52.38M(-21.8%) | -$206.74M(-10.6%) |
| Mar 2022 | - | -$42.99M(+22.7%) | -$186.90M(+17.6%) |
| Dec 2021 | -$226.73M(-86.8%) | -$55.63M(+0.2%) | -$226.73M(+15.0%) |
| Sep 2021 | - | -$55.74M(-71.3%) | -$266.67M(+8.5%) |
| Jun 2021 | - | -$32.53M(+60.7%) | -$291.48M(-124.6%) |
| Mar 2021 | - | -$82.82M(+13.3%) | -$129.77M(-6.9%) |
| Dec 2020 | -$121.40M(-30.4%) | -$95.57M(-18.6%) | -$121.40M(-43.2%) |
| Sep 2020 | - | -$80.55M(-162.4%) | -$84.79M(-21.1%) |
| Jun 2020 | - | $129.17M(+273.5%) | -$70.01M(+72.5%) |
| Mar 2020 | - | -$74.45M(-26.3%) | -$254.48M(-173.3%) |
| Dec 2019 | -$93.10M(+54.5%) | -$58.96M(+10.3%) | -$93.10M(+1.8%) |
| Sep 2019 | - | -$65.77M(-18.9%) | -$94.79M(-19.1%) |
| Jun 2019 | - | -$55.30M(-163.6%) | -$79.58M(-12.5%) |
| Mar 2019 | - | $86.93M(+243.3%) | -$70.76M(+65.4%) |
| Dec 2018 | -$204.59M | -$60.65M(-19.9%) | -$204.59M(-12.0%) |
| Sep 2018 | - | -$50.56M(-8.8%) | -$182.63M(-2.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | -$46.48M(+0.9%) | -$177.81M(-1.6%) |
| Mar 2018 | - | -$46.89M(-21.2%) | -$174.99M(-3.6%) |
| Dec 2017 | -$168.98M(-121.9%) | -$38.70M(+15.4%) | -$168.98M(-5.9%) |
| Sep 2017 | - | -$45.74M(-4.8%) | -$159.57M(-21.3%) |
| Jun 2017 | - | -$43.66M(-6.8%) | -$131.55M(-28.7%) |
| Mar 2017 | - | -$40.89M(-39.6%) | -$102.22M(-34.2%) |
| Dec 2016 | -$76.15M(-52.2%) | -$29.29M(-65.3%) | -$76.15M(-26.7%) |
| Sep 2016 | - | -$17.71M(-23.6%) | -$60.10M(-8.7%) |
| Jun 2016 | - | -$14.33M(+3.3%) | -$55.31M(-3.5%) |
| Mar 2016 | - | -$14.82M(-12.0%) | -$53.44M(-6.8%) |
| Dec 2015 | -$50.04M(-38.1%) | -$13.23M(-2.4%) | -$50.04M(-8.3%) |
| Sep 2015 | - | -$12.92M(-3.7%) | -$46.19M(-7.5%) |
| Jun 2015 | - | -$12.46M(-9.1%) | -$42.97M(-8.1%) |
| Mar 2015 | - | -$11.43M(-21.8%) | -$39.76M(-9.8%) |
| Dec 2014 | -$36.22M(-59.2%) | -$9.38M(+3.3%) | -$36.22M(+1.0%) |
| Sep 2014 | - | -$9.70M(-4.8%) | -$36.58M(-13.3%) |
| Jun 2014 | - | -$9.25M(-17.3%) | -$32.29M(-18.2%) |
| Mar 2014 | - | -$7.89M(+19.0%) | -$27.30M(-20.0%) |
| Dec 2013 | -$22.76M(-123.0%) | -$9.74M(-80.1%) | -$22.76M(-74.8%) |
| Sep 2013 | - | -$5.41M(-26.6%) | -$13.02M(-71.0%) |
| Jun 2013 | - | -$4.27M(-27.7%) | -$7.62M(-127.7%) |
| Mar 2013 | - | -$3.34M(-52.7%) | -$3.34M(-52.7%) |
| Dec 2012 | -$10.20M(-0.4%) | - | - |
| Mar 2012 | - | -$2.19M | -$2.19M |
| Dec 2011 | -$10.16M(+65.2%) | - | - |
| Dec 2002 | -$29.24M(+0.3%) | - | - |
| Dec 2001 | -$29.33M(-6.4%) | - | - |
| Dec 2000 | -$27.57M(-122.9%) | - | - |
| Dec 1999 | -$12.37M | - | - |
FAQ
- What is Esperion Therapeutics, Inc. annual operating income?
- What is the all-time high annual operating profit for Esperion Therapeutics, Inc.?
- What is Esperion Therapeutics, Inc. annual operating profit year-on-year change?
- What is Esperion Therapeutics, Inc. quarterly operating income?
- What is the all-time high quarterly operating profit for Esperion Therapeutics, Inc.?
- What is Esperion Therapeutics, Inc. quarterly operating profit year-on-year change?
- What is Esperion Therapeutics, Inc. TTM operating income?
- What is the all-time high TTM operating profit for Esperion Therapeutics, Inc.?
- What is Esperion Therapeutics, Inc. TTM operating profit year-on-year change?
What is Esperion Therapeutics, Inc. annual operating income?
The current annual operating profit of ESPR is $54.40M
What is the all-time high annual operating profit for Esperion Therapeutics, Inc.?
Esperion Therapeutics, Inc. all-time high annual operating income is $54.40M
What is Esperion Therapeutics, Inc. annual operating profit year-on-year change?
Over the past year, ESPR annual operating income has changed by +$209.97M (+134.97%)
What is Esperion Therapeutics, Inc. quarterly operating income?
The current quarterly operating profit of ESPR is -$9.96M
What is the all-time high quarterly operating profit for Esperion Therapeutics, Inc.?
Esperion Therapeutics, Inc. all-time high quarterly operating income is $129.17M
What is Esperion Therapeutics, Inc. quarterly operating profit year-on-year change?
Over the past year, ESPR quarterly operating income has changed by +$6.07M (+37.86%)
What is Esperion Therapeutics, Inc. TTM operating income?
The current TTM operating profit of ESPR is -$29.38M
What is the all-time high TTM operating profit for Esperion Therapeutics, Inc.?
Esperion Therapeutics, Inc. all-time high TTM operating income is $54.40M
What is Esperion Therapeutics, Inc. TTM operating profit year-on-year change?
Over the past year, ESPR TTM operating income has changed by -$58.94M (-199.41%)